HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Splenic infarction. Ergotism induced by ritonavir?].

Abstract
Ergotism is a clinical condition known since old times and whose main characteristics are ischemia and even limb gangrene. Some drugs have the capacity of interacting with small amounts of ergotamine or its derivatives producing ergotism as a side effect. This is the case of ritonavir, a widely used anti-HIV drug. Here we present a case of ergotism that developed in an HIV positive 39 year old male under treatment with ritonavir, after taking 1 mg of ergotamine tartrate. His clinical picture, apart from showing the basic manifestations of the disease, was associated with splenic infarction. For this reason, we consider important to advise patients about the potential pharmacological interaction between ergotamines and others common drugs and, in particular, ritonavir in HIV positive patients.
AuthorsAgustín Dal Verme, Emiliano López, Sebastián Grinspon, Rocío Fernández Pardal, Mariano Mengia, Octavio Mazzocchi
JournalMedicina (Medicina (B Aires)) Vol. 72 Issue 6 Pg. 475-7 ( 2012) ISSN: 0025-7680 [Print] Argentina
Vernacular TitleInfarto esplénico. ¿Ergotismo inducido por ritonavir?
PMID23241290 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • HIV Protease Inhibitors
  • Vasoconstrictor Agents
  • Ritonavir
  • Ergotamine
Topics
  • Adult
  • Drug Interactions
  • Ergotamine (adverse effects)
  • Ergotism (etiology)
  • HIV Infections (drug therapy)
  • HIV Protease Inhibitors (adverse effects)
  • Humans
  • Male
  • Ritonavir (adverse effects)
  • Splenic Infarction (chemically induced)
  • Tomography, X-Ray Computed
  • Vasoconstrictor Agents (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: